Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Katsuyuki, Miki"'
Autor:
Naoto Okubo, Katsuyuki Miki, Masayuki Yamanouchi, Daisuke Ikuma, Hiroki Mizuno, Yuki Oba, Akinari Sekine, Eiko Hasegawa, Tatsuya Suwabe, Junichi Hoshino, Takayoshi Yokoyama, Yasuo Ishii, Kei Kono, Keiichi Kinowaki, Kenichi Ohashi, Yutaka Yamaguchi, Naoki Sawa, Yuki Nakamura, Yoshifumi Ubara
Publikováno v:
Transplantation Proceedings. 54:2748-2753
We performed a deceased-donor kidney transplantation on a 64-year-old woman. The donor was a 57-year-old man with a history of diabetes mellitus. A kidney biopsy showed nodular sclerosis, Tervaert class 3 diabetic nephropathy. Six months after surger
Publikováno v:
Transplantation Reports, Vol 5, Iss 3, Pp 100047- (2020)
Background: The use of laparoscopy is increasing in various surgical disciplines, including living donor kidney transplant (LDKT). In laparoscopic transplants, vessel length of the donor kidneys often falls short. This makes anastomosis to the recipi
Externí odkaz:
https://doaj.org/article/13c2fc7438264794a9833a709b4d79ad
Autor:
Yusuke Tomita, Kazuhiro Iwadoh, Yuichi Ogawa, Katsuyuki Miki, Yojiro Kato, Kotaro Kai, Akihito Sannomiya, Ichiro Koyama, Kumiko Kitajima, Ichiro Nakajima, Shohei Fuchinoue
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0224203 (2019)
This study was conducted to evaluate de novo donor-specific anti-human leukocyte antigen (HLA) antibody (dnDSA) production leading to antibody-mediated rejection (ABMR) after rituximab induction in non-sensitized ABO-compatible living kidney transpla
Externí odkaz:
https://doaj.org/article/d18b0819fa9c40d4b23ace1d10dfd6df
Publikováno v:
Transplantation Proceedings. 54:671-677
Roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, has been reported to be effective in treating conservative renal failure and renal anemia in patients undergoing dialysis. Nonetheless, its effect on posttransplant anemia (PTA) has
Autor:
Atsuhiko Suenaga, Naoki Sawa, Katsuyuki Miki, Takayoshi Yokoyama, Yasuo Ishii, Hiroki Mizuno, Daisuke Ikuma, Yuki Oba, Akinari Sekine, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, Kei Kono, Keiichi Kinowaki, Kenichi Ohashi, Kazuho Honda, Motoaki Miyazono, Yuki Nakamura, Yoshifumi Ubara
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 18, p2707-2713, 7p
Autor:
Atsuhiko Suenaga, Naoki Sawa, Katsuyuki Miki, Takayoshi Yokoyama, Yasuo Ishii, Hiroki Mizuno, Daisuke Ikuma, Yuki Oba, Akinari Sekine, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, Kei Kono, Keiichi Kinowaki, Kenichi Ohashi, Kazuho Honda, Motoaki Miyazono, Yuki Nakamura, Yoshifumi Ubara
Publikováno v:
Internal Medicine.
Autor:
Yusuke Tomita, MD, Kazuhiro Iwadoh, MD, Yuichi Ogawa, MD, Katsuyuki Miki, MD, Kotaro Kai, MD, Akihito Sannomiya, MD, Toru Murakami, MD, Ichiro Koyama, MD, Kumiko Kitajima, MD, Ichiro Nakajima, MD, Shohei Fuchinoue, MD
Publikováno v:
Transplantation Direct, Vol 4, Iss 4, p e355 (2018)
Abstract. Chronic shortages of organs for transplantation have led to the use of marginal kidneys from donors after circulatory death with acute kidney injury (AKI), but the utilization of kidneys with severe AKI is not well established. We retrospec
Externí odkaz:
https://doaj.org/article/d0069f1c95384324829d698a12d7ec2a
Autor:
Yoshifumi Ubara, Katsuyuki Miki, Yasuo Ishii, Naoki Sawa, Suguru Tatsuki, Yuki Nakamura, T. Yokoyama, Koji Tanaka
Publikováno v:
Transplantation Proceedings. 53:1831-1835
Background After the revised organ transplant law came into effect in Japan, donations of organs under brain death have been increasing; however, because of the expansion of donor indications, donations from expanded criteria donors and cardiac arres
Publikováno v:
Transplantation Proceedings. 53:1288-1291
Background Kidney transplantation in patients with cardiac hypofunction is challenging. Even if the surgery is successfully performed, these patients may suffer from low output cardiac function. We report the case of a patient with severe cardiac hyp
Publikováno v:
Transplantation Proceedings. 52:1680-1683
Background Renal transplantation in patients with autosomal dominant polycystic kidney disease (ADPKD) remains a feasible option because no recurrence has been reported. Transcatheter arterial embolization (TAE) for patients with ADPKD is performed t